Chinese companies have over the past five years obtained exclusive distribution rights in Taiwan for 29 percent of new pharmaceuticals, the Legislative Yuan said, urging the government to intervene, as it said the issue extends far beyond Chinese agency over the Pfizer-BioNTech COVID-19 vaccine.
Right of agency for drug distribution has received widespread attention this year, after Germany’s BioNTech inked a deal with Shanghai Fosun Pharmaceutical Group (上海復星醫藥集團) to develop and distribute its COVID-19 vaccine in Taiwan, China, Hong Kong and Macau.
This has complicated Taipei’s efforts to procure the vaccine.
Private entities have stepped in to purchase doses to donate to the government, including Taiwan Semiconductor Manufacturing Co (台積電), the Buddhist Compassion Relief Tzu Chi Foundation and the Hon Hai Precision Industry Co (鴻海精密)-affiliated Yonglin Foundation.
In a report dated Monday, the Legislative Yuan’s Judiciary and Organic Laws and Statutes Bureau decried the arrangement as unreasonable.
“Requiring South Korea to purchase vaccines through a North Korean distributor or Israel to go through a Palestinian firm would be preposterous,” the report said.
Granting exclusive distribution rights in a nation to its political and military adversary is ethically problematic, it said.
Due to the antagonism and mutual distrust between the two nations, it is highly unlikely that they would complete a contract and instead use it as a tool for political manipulation, it added.
This would further hinder transactions and jeopardize the right to healthcare of the “represented country,” the report added.
Right of agency over pharmaceuticals has long been an issue, the bureau said.
Over the past five years, Chinese firms have obtained exclusive distribution rights to Taiwan for 29 percent of new pharmaceuticals, posing an increasingly serious problem that cannot be ignored, it said.
The bureau recommended that the Ministry of Foreign Affairs and national security agencies intervene in China’s attempts to monopolize Taiwan’s pharmaceutical market.
Using appropriate channels, officials should persuade multinationals to avoid signing right-of-agency contracts for Taiwan with Chinese distributors, thereby preventing human rights, moral and political controversies, it said.
All import licensing procedures should follow WTO protocols, as Taiwan, Germany and China are all members of the global trade body, the report added, recommending that the Ministry of Economic Affairs seek a decision from the WTO or another international economic forum to ensure fair and timely access to vaccines worldwide.
EUROPEAN TARGETS: The planned Munich center would support TSMC’s European customers to design high-performance, energy-efficient chips, an executive said Taiwan Semiconductor Manufacturing Co (TSMC, 台積電), the world’s largest contract chipmaker, yesterday said that it plans to launch a new research-and-development (R&D) center in Munich, Germany, next quarter to assist customers with chip design. TSMC Europe president Paul de Bot made the announcement during a technology symposium in Amsterdam on Tuesday, the chipmaker said. The new Munich center would be the firm’s first chip designing center in Europe, it said. The chipmaker has set up a major R&D center at its base of operations in Hsinchu and plans to create a new one in the US to provide services for major US customers,
The Ministry of Transportation and Communications yesterday said that it would redesign the written portion of the driver’s license exam to make it more rigorous. “We hope that the exam can assess drivers’ understanding of traffic rules, particularly those who take the driver’s license test for the first time. In the past, drivers only needed to cram a book of test questions to pass the written exam,” Minister of Transportation and Communications Chen Shih-kai (陳世凱) told a news conference at the Taoyuan Motor Vehicle Office. “In the future, they would not be able to pass the test unless they study traffic regulations
GAINING STEAM: The scheme initially failed to gather much attention, with only 188 cards issued in its first year, but gained popularity amid the COVID-19 pandemic Applications for the Employment Gold Card have increased in the past few years, with the card having been issued to a total of 13,191 people from 101 countries since its introduction in 2018, the National Development Council (NDC) said yesterday. Those who have received the card have included celebrities, such as former NBA star Dwight Howard and Australian-South Korean cheerleader Dahye Lee, the NDC said. The four-in-one Employment Gold Card combines a work permit, resident visa, Alien Resident Certificate (ARC) and re-entry permit. It was first introduced in February 2018 through the Act Governing Recruitment and Employment of Foreign Professionals (外國專業人才延攬及雇用法),
‘A SURVIVAL QUESTION’: US officials have been urging the opposition KMT and TPP not to block defense spending, especially the special defense budget, an official said The US plans to ramp up weapons sales to Taiwan to a level exceeding US President Donald Trump’s first term as part of an effort to deter China as it intensifies military pressure on the nation, two US officials said on condition of anonymity. If US arms sales do accelerate, it could ease worries about the extent of Trump’s commitment to Taiwan. It would also add new friction to the tense US-China relationship. The officials said they expect US approvals for weapons sales to Taiwan over the next four years to surpass those in Trump’s first term, with one of them saying
RSS